A Proof of Concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma

Condition:   GlioblastomaInterventions:   Drug: Temozolomide;   Drug: Aprepitant;   Drug: Minocycline;   Drug: Disulfiram;   Drug: Celecoxib;   Drug: Sertraline;   Drug: Captopril;   Drug: Itraconazole;   Drug: Ritonavir;   Drug: AuranofinSponsors:   University of Ulm;   Reliable Cancer Therapies;   Anticancer Fund, BelgiumNot yet recruiting - verified May 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials